Early stage breast cancerLate toxicitySecond cancer mortalitySurveillance, Epidemiology, and End Results (SEERINTRODUCTION/: With improved BC screening and treatment, the risk for long-term toxicities of treatments must be considered, especially in good prognosis patients. In this study we examined the...
Breast Cancer Recurrence, Early Stage 1, 2 Breast Cancer Test, Prognostic Test For Breast Cancer In India, Tumour Test, Screening Test, Oncotype dx Test in India, CanAssistBreast, Oncostem, India
News & Views20 Nov 2024Nature Genetics Volume: 56, P: 2594-2595 First-line triplet therapy for advanced-stagePIK3CA-mutant HR+breast cancer improves outcomes David Killock Research Highlights12 Nov 2024Nature Reviews Clinical Oncology Volume: 22, P: 1 Nature.com...
Breast cancer, disease characterized by the growth of malignant cells in the mammary glands. Breast cancer can strike males and females, although women are about 100 times more likely to develop the disease than men. Most cancers in female breasts form s
Patritumab deruxtecan (HER3-DXd) is a promising therapy for breast cancer, targeting HER3. Here, the authors analyse the genomic factors that affect the response to HER3-DXd in patients with early-stage HER2-negative breast cancer as part of the SOLTI-1805 TOT-HER3 clinical trial and repo...
stage_0_breast-patient NCCN 指南 for patients 乳房是由乳管、脂肪、神经、血管、淋巴管、韧带和其他结缔组织组成的腺状器官。 高和低乳房x线照相术密度之间的生物学差异 Biological differences between high and low mammographic density Ref: 2019 Key steps for effective brea...
Pathologic predictor of recurrence in stage 1 breast cancer The T1, N0, M0 subset of stage I lung adenocarcinoma is a tumor that has a 5-year disease-free survival rate of 66% to 85%. To date, there has not been a r... AD Roses,DA Bell,TJ Flote,... 被引量: 95发表: 1982年 ...
1/3 If you catch breast cancer early and complete your treatment, you don’t need to worry about follow-up treatment. True False 2/3 What determines the next step in your treatment after surgery? The tumor’s size The type of tumor Your menopause status All of the above 3/3 Breast ca...
1C, D). Furthermore, high SEC61G expression in breast cancer patients with tumor, nodes, and metastases (TNM) stage I–II or TNM III–IV also exhibited markedly lower rates of overall survival and disease-free survival compared with patients with low SEC61G expression (Fig. 1E, F). ...
1C). Besides, expression of CYB561 in BRCA based on individual cancer stage, histology subtypes, patient’s race, menopause status were higher than the normal (Fig. S1A–D). The results of the Human Protein Atlas (HPA) database analysis showed that certain ductal and lobular carcinomas ...